Clinical Trials Directory

Trials / Completed

CompletedNCT00626366

Distribution of Topical Nasal Medication Within the Nasal Cavity and Sinuses by Radiographic Comparison

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
University of Nebraska · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used.

Detailed description

The purpose of this study is to determine the distribution of nasal sprays and nasal drops when used. The study hypothesizes that nasal drops will reach the frontonasal region more often than nasal sprays.

Conditions

Interventions

TypeNameDescription
RADIATIONSinus CT ScanSubjects will undergo a Xoran miniCAT scan of their sinuses
DRUGOmnipaque 240 Contrast SolutionSubjects will spray 2-4 drops of half-strength Omnipaque 240 mgI/mL into each nare. Each spray is approximately 0.1 ml.
DRUGOmnipaque 240 mg I/mLSubjects will place two drops of half-strength Omnipaque 240 mg I/mL intranasally to each nose. Each drop is approximately 1 ml.

Timeline

Start date
2008-03-12
Primary completion
2009-01-09
Completion
2009-01-09
First posted
2008-02-29
Last updated
2023-09-28
Results posted
2019-08-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00626366. Inclusion in this directory is not an endorsement.